ClinicalTrials.govpublic full text
MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma
melanoma, metastatic,, melanoma,, antigen-specific cancer immunotherapeutic,, asci, mage-a3, tumor antigen,, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831318
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.